Author Correction: CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells
- PMID: 31043737
- DOI: 10.1038/s41586-019-1133-3
Author Correction: CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells
Abstract
Further analysis has revealed that the signal reported in Extended Data Fig. 1c of this Letter is attributed to phosphorylethanolamine, not carbamoyl phosphate. A newly developed derivatization method revealed that the level of carbamoyl phosphate in these NSCLC extracts is below the detection threshold of approximately 10 nanomoles. These findings do not alter the overall conclusions of the Letter; see associated Amendment for full details. The Letter has not been corrected online.
Erratum for
-
CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells.Nature. 2017 Jun 1;546(7656):168-172. doi: 10.1038/nature22359. Epub 2017 May 24. Nature. 2017. PMID: 28538732 Free PMC article.
References
-
- Lowenstein, J. M. & Cohen, P. P. Studies on the biosynthesis of carbamylaspartic acid. J. Biol. Chem. 220, 57–70 (1956). - PubMed
-
- Wang, Q., Xia, J., Guallar, V., Krilov, G. & Kantrowitz, E. R. Mechanism of thermal decomposition of carbamoyl phosphate and its stabilization by aspartate and ornithine transcarbamoylases. Proc. Natl Acad. Sci. USA 105, 16918–16923 (2008). - DOI
-
- Haviv, F. et al. 3-[1-(2-Benzoxazolyl)hydrazino]propanenitrile derivatives: inhibitors of immune complex induced inflammation. J. Med. Chem. 31, 1719–1728 (1988). - DOI
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
